Summary
The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.
Biosimilars Forum 2019 is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.
Join us in Mexico and trigger a quantum leap in Latin American Healthcare!
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Speakers
Thomas Kirchlechner
Sandoz, Austri
Director Regulatory Policy
Perla Villani Borges
Bio-Manguinhos / Fiocruz, Brazil
Business Development Manager
Joseph Park
Samsung Bioepis, South Korea
Senior Manager of Regulatory Affairs, Regulatory Strategy and Policy
Rivelino Flores
CANIFARMA, Mexico
Director of Regulatory Affairs and Innovation
Regulatory Framework in Brazil and Mexico
Maria Fernanda Thees ANVISA, Brazil Health Regulation and Surveillance Specialist
Invited: COFEPRIS
Current Development and Regulatory Challenges in the Region
Éctor Jaime Ramírez
National Action Party of Guanajuato, Mexico
Federal Deputy LXIV Legislature and Secretary of the Health Commission
Ricardo Castro
Neolpharma, Mexico
Biotechnology Manager
New Commercial Agreements in the region How to Make a Commercial Decision Based on Competitors and Management Models to Boost Biosimilars
Eduardo Cioppi
mAbxience, Argentina
Regional Director – Latin America
Nicolas Linares, sent
Ultragenyx Pharmaceutical, Mexico
Executive Director & General Manager
Expectations from the Mexican Academy
Laura Palomares,
UNAM, Mexico
Researcher and Professor
Regulatory Harmonisation Activities by Brazil and Mexico
Maria Fernanda Thees
ANVISA, Brazil
Health Regulation and Surveillance Specialist
Invited: COFEPRIS
Pharmacovigilance. Signal Management. Safety Surveillance. Risk communication
Nestor Lago
Gemabiotech, Argentina
Medical Director